BIOMAT Database Logo BIOMAT Database Logo

[Gliclazide, a new antidiabetic with hemobiologic and vascular properties]. 1972

M Plauchu, and G Pousset

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Plauchu, and G Pousset
[Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
January 1972, Therapeutique (La Semaine des hopitaux),
M Plauchu, and G Pousset
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
January 1972, Marseille medical,
M Plauchu, and G Pousset
[Therapeutic value of a new oral antidiabetic agent: gliclazide].
March 1978, La Clinica terapeutica,
M Plauchu, and G Pousset
[Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
May 1976, Journees annuelles de diabetologie de l'Hotel-Dieu,
M Plauchu, and G Pousset
Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
January 1980, Upsala journal of medical sciences,
M Plauchu, and G Pousset
Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles.
August 2021, Pharmaceuticals (Basel, Switzerland),
M Plauchu, and G Pousset
Is gliclazide a new antidiabetic drug implicated in the pathogenesis of ocular mucous membrane pemphigoid?
June 2018, European journal of dermatology : EJD,
M Plauchu, and G Pousset
Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin.
October 2008, Chemical biology & drug design,
M Plauchu, and G Pousset
Gliclazide: metabolic and vascular effects--a perspective.
May 1992, Metabolism: clinical and experimental,
M Plauchu, and G Pousset
[Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
October 1972, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
Copied contents to your clipboard!